Neurodegeneration and Neuroprotection in Parkinson Disease
Summary: Many of the motoric features that define Parkinson disease (PD) result primarily from the loss of the neuromelanin (NM)-containing dopamine (DA) neurons of the substantia nigra (SN), and to a lesser extent, other mostly catecholaminergic neurons, and are associated with cytoplasmic “Lewy bo...
Guardado en:
| Publicado en: | NeuroRx |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Am. Soc. for Experimental NeuroTherapeutics
2004
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC534919/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15717014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1602/neurorx.1.1.139 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|